XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Commitments and Contingencies (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Jun. 10, 2022
Mar. 03, 2022
Mar. 31, 2023
Jun. 30, 2022
Dec. 31, 2022
Loss Contingencies [Line Items]          
Estimated litigation cost     $ 5.9   $ 5.9
litigation paid percent         100.00%
Harvard Bioscience Inc. [Member]          
Loss Contingencies [Line Items]          
Litigation amount received     $ 4.0 $ 4.0  
Harvard Bioscience Inc. [Member] | Convertible Preferred Stock [Member]          
Loss Contingencies [Line Items]          
Preferred stock, dividend rate, percentage     8.00%    
Harvard Bioscience Inc. [Member] | Series E 8% Convertible Preferred Stock [Member]          
Loss Contingencies [Line Items]          
Litigation amount received $ 4.0        
Preferred stock, dividend rate, percentage 8.00%        
Temporary equity, stock issued 4,000        
Temporary equity, issue price per share $ 1,000        
Accrual for contingency matter $ 3.3        
Legal costs on claims against insurance carrier $ 0.8        
Medmarc [Member]          
Loss Contingencies [Line Items]          
Cash payment received on litigation   $ 0.1